Poor concordance regarding prognosis and goals of care; variation seen by cancer type.
In advanced cancer patients receiving opioids, methylprednisolone does not add to analgesic effect.
Researchers call for careful assessment of need for long-term CVCs and targeted strategies for reducing infections.
Two classes of antidepressants may alleviate cancer-related depressive symptoms.
More effort is needed to enhance the follow-up care of cancer survivors.
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
But 95 percent of palliative care staff indicate that patients die with dignity in their wards.
There is still more work to be done to ensure that palliative care is understood.
CHICAGO, IL— Family members caring for patients with advanced cancer benefit from early initiation of phone-based training and support.
Patricia Ganz, MD, offers advice on how to "change the conversation" on palliative care.
New legislation aims to mandate action on an important aspect of cancer care.
NDA submitted for rolapitant for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Blocking the effects of parathyroid hormone-related protein may improve or prevent cachexia.
This fact sheet offers tips for patients to help keep their memory sharp during cancer treatment.
Results revealed a decrease in brain activation while performing a multitasking exercise among women with breast cancer who had undergone chemotherapy.
Eisai and the Helsinn Group announced that the FDA has approved Aloxi (palonosetron HCl) injection for the prevention of acute nausea and vomiting due to chemotherapy in children aged 1 month to less than 17 years.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|